BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 20494994)

  • 1. Variation in Streptococcus pyogenes NAD+ glycohydrolase is associated with tissue tropism.
    Riddle DJ; Bessen DE; Caparon MG
    J Bacteriol; 2010 Jul; 192(14):3735-46. PubMed ID: 20494994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Streptococcus pyogenes NAD(+) glycohydrolase modulates epithelial cell PARylation and HMGB1 release.
    Chandrasekaran S; Caparon MG
    Cell Microbiol; 2015 Sep; 17(9):1376-90. PubMed ID: 25818652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The NADase-Negative Variant of the Streptococcus pyogenes Toxin NAD⁺ Glycohydrolase Induces JNK1-Mediated Programmed Cellular Necrosis.
    Chandrasekaran S; Caparon MG
    mBio; 2016 Feb; 7(1):e02215-15. PubMed ID: 26838722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of polymorphic residues reveals distinct enzymatic and cytotoxic activities of the Streptococcus pyogenes NAD+ glycohydrolase.
    Chandrasekaran S; Ghosh J; Port GC; Koh EI; Caparon MG
    J Biol Chem; 2013 Jul; 288(27):20064-75. PubMed ID: 23689507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel endogenous inhibitor of the secreted streptococcal NAD-glycohydrolase.
    Meehl MA; Pinkner JS; Anderson PJ; Hultgren SJ; Caparon MG
    PLoS Pathog; 2005 Dec; 1(4):e35. PubMed ID: 16333395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural basis of Streptococcus pyogenes immunity to its NAD+ glycohydrolase toxin.
    Smith CL; Ghosh J; Elam JS; Pinkner JS; Hultgren SJ; Caparon MG; Ellenberger T
    Structure; 2011 Feb; 19(2):192-202. PubMed ID: 21300288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding of NAD
    Velarde JJ; O'Seaghdha M; Baddal B; Bastiat-Sempe B; Wessels MR
    mBio; 2017 Sep; 8(5):. PubMed ID: 28900022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular epidemiology of nga and NAD glycohydrolase/ADP-ribosyltransferase activity among Streptococcus pyogenes causing streptococcal toxic shock syndrome.
    Stevens DL; Salmi DB; McIndoo ER; Bryant AE
    J Infect Dis; 2000 Oct; 182(4):1117-28. PubMed ID: 10979908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure of the Streptococcus pyogenes NAD
    Velarde JJ; Piai A; Lichtenstein IJ; Lynskey NN; Chou JJ; Wessels MR
    J Bacteriol; 2022 Jan; 204(1):e0036621. PubMed ID: 34694903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the NAD-glycohydrolase in streptococcal strains.
    Tatsuno I; Sawai J; Okamoto A; Matsumoto M; Minami M; Isaka M; Ohta M; Hasegawa T
    Microbiology (Reading); 2007 Dec; 153(Pt 12):4253-4260. PubMed ID: 18048938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-resolution crystal structure of Streptococcus pyogenes β-NAD⁺ glycohydrolase in complex with its endogenous inhibitor IFS reveals a highly water-rich interface.
    Yoon JY; An DR; Yoon HJ; Kim HS; Lee SJ; Im HN; Jang JY; Suh SW
    J Synchrotron Radiat; 2013 Nov; 20(Pt 6):962-7. PubMed ID: 24121349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The NAD-glycohydrolase (nga) gene of Streptococcus pyogenes.
    Ajdic D; McShan WM; Savic DJ; Gerlach D; Ferretti JJ
    FEMS Microbiol Lett; 2000 Oct; 191(2):235-41. PubMed ID: 11024269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trading Capsule for Increased Cytotoxin Production: Contribution to Virulence of a Newly Emerged Clade of emm89 Streptococcus pyogenes.
    Zhu L; Olsen RJ; Nasser W; de la Riva Morales I; Musser JM
    mBio; 2015 Oct; 6(5):e01378-15. PubMed ID: 26443457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of Streptococcus pyogenes beta-NAD+ glycohydrolase: re-evaluation of enzymatic properties associated with pathogenesis.
    Ghosh J; Anderson PJ; Chandrasekaran S; Caparon MG
    J Biol Chem; 2010 Feb; 285(8):5683-94. PubMed ID: 20018886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of Inflammasome-Dependent Interleukin 1β Production by Streptococcal NAD
    Hancz D; Westerlund E; Bastiat-Sempe B; Sharma O; Valfridsson C; Meyer L; Love JF; O'Seaghdha M; Wessels MR; Persson JJ
    mBio; 2017 Jul; 8(4):. PubMed ID: 28720729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NAD+-Glycohydrolase Promotes Intracellular Survival of Group A Streptococcus.
    Sharma O; O'Seaghdha M; Velarde JJ; Wessels MR
    PLoS Pathog; 2016 Mar; 12(3):e1005468. PubMed ID: 26938870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of Secreted NADase and Streptolysin O to the Pathogenesis of Epidemic Serotype M1 Streptococcus pyogenes Infections.
    Zhu L; Olsen RJ; Lee JD; Porter AR; DeLeo FR; Musser JM
    Am J Pathol; 2017 Mar; 187(3):605-613. PubMed ID: 28034602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Streptolysin O and its co-toxin NAD-glycohydrolase protect group A Streptococcus from Xenophagic killing.
    O'Seaghdha M; Wessels MR
    PLoS Pathog; 2013; 9(6):e1003394. PubMed ID: 23762025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NADase as a target molecule of in vivo suppression of the toxicity in the invasive M-1 group A Streptococcal isolates.
    Tatsuno I; Isaka M; Minami M; Hasegawa T
    BMC Microbiol; 2010 May; 10():144. PubMed ID: 20470439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Streptolysin O and NAD-glycohydrolase prevent phagolysosome acidification and promote group A Streptococcus survival in macrophages.
    Bastiat-Sempe B; Love JF; Lomayesva N; Wessels MR
    mBio; 2014 Sep; 5(5):e01690-14. PubMed ID: 25227466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.